EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria

Yvonne Mücke iD, Natalia Jablonka, Nicole Rimann, Hiu Man Grisch-Chan, Bernhard Hoffmann, Stefan Schillberg, Beat Thöny iD, Stefan Rasche

Journal of Inherited Metabolic Disease · 2024-07 · 47 (4) · 651-663

DOI: 10.1002/jimd.12719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 23.02.2024. Verfasst von Yvonne Mücke und 7 weiteren Autor:innen. Beteiligte Einrichtung: metaX Institut für Diätetik GmbH, Friedberg, Germany. Hauptthemen laut MEDLINE: Phenylalanine, Phenylketonurias, Recombinant Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BMBF;KMUinnovativ:Biotechnologie-BioChance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenylketonuria (PKU) is a congenital metabolic disorder that causes the systemic elevation of phenylalanine (Phe), which is neurotoxic and teratogenic. PKU is currently incurable, and management involves lifelong adherence to an unpalatable protein‐restricted diet based on Phe‐free amino acid mixtures. Seeking a palatable dietary alternative, we identified a Bacillus subtilis protein (GSP16O) with a well‐balanced but low‐Phe amino acid profile. We optimized the sequence and expressed a modified Phe‐free version (GSP105) in Pseudomonas fluorescens , achieving yields of 20 g/L. The purified GSP105 protein has a neutral taste and smell, is highly soluble, and remains stable up to 80°C. Homozygous enu2 mice, a model of human PKU, were fed with diets containing either GSP105 or normal protein. The GSP105 diet led to normalization of blood Phe levels and brain monoamine neurotransmitter metabolites, and prevented maternal PKU. The GSP105 diet thus provides an alternative and efficacious dietary management strategy for PKU.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylalaninePhenylketonuriasRecombinant ProteinsAnimalsMiceHumansFemaleDisease Models, AnimalBacillus subtilisDietary ProteinsDiet, Protein-RestrictedBacterial Proteins

Stichwörter der Autor:innen

Pseudomonas fluorescensbiotechnologydietary proteinenu2 modelphenylalaninephenylketonuria

Substanzen

PhenylalanineRecombinant ProteinsDietary ProteinsBacterial Proteins

Autor:innen und Institutionen

  • metaX Institut für Diätetik GmbH, Friedberg, Germany.
  • Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME, Aachen, Germany.
  • Division of Metabolism, Department of Pediatrics, University of Zürich, Zürich, Switzerland.

ORCID-Profile: Yvonne Mücke, Beat Thöny

Förderung

  • BMBF;KMUinnovativ:Biotechnologie-BioChance

Zitieren

APA

Mücke, Y., Jablonka, N., Rimann, N., Grisch-Chan, H. M., Hoffmann, B., Schillberg, S., Thöny, B., & Rasche, S. (2024). A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria. Journal of Inherited Metabolic Disease, 47(4), 651-663. https://doi.org/10.1002/jimd.12719

Vancouver

Mücke Y, Jablonka N, Rimann N, Grisch-Chan HM, Hoffmann B, Schillberg S, et al. A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria. Journal of Inherited Metabolic Disease. 2024;47(4):651-663. doi:10.1002/jimd.12719

BibTeX
@article{Mcke2024,
  author = {Mücke, Yvonne and Jablonka, Natalia and Rimann, Nicole and Grisch-Chan, Hiu Man and Hoffmann, Bernhard and Schillberg, Stefan and Thöny, Beat and Rasche, Stefan},
  title = {A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2024},
  volume = {47},
  number = {4},
  pages = {651--663},
  doi = {10.1002/jimd.12719}
}
Kostenlos starten →